我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

内脏脂肪素对巨噬细胞中EMMPRIN表达的影响及其机制的探讨

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2010年第3期
页码:
313-317
栏目:
基础研究
出版日期:
2010-04-06

文章信息/Info

Title:
Effect and mechanism of visfatin activity on EMMPRIN expression in macrophages
作者:
范虞琪; 何奔; 王彬尧
上海交通大学医学院仁济医院心内科，上海 200001
Author(s):
FAN Yu-qi;  HE Ben;  WANG Bin-yao
Department of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200001, China
关键词:
内脏脂肪素; 细胞外基质金属蛋白酶诱导因子; 丝裂原活化蛋白激酶; 动脉粥样硬化
Keywords:
visfatin;  extracellular matrix metalloproteinase inducer;  mitogen-activated protein kinase (MAPK);  atherosclerosis
分类号:
R543.5
DOI:
-
文献标识码:
A
摘要:
目的: 研究内脏脂肪素（visfatin,Vis）对巨噬细胞细胞外基质金属蛋白酶诱导因子(EMMPRIN)表达的影响及其机制。方法: 诱导THP-1单核细胞转化为巨噬细胞后，加入Vis，用RT-PCR和Western blot分别测定EMMPRIN基因和其蛋白的表达。以丝裂原活化蛋白激酶（MAPK）信号通路抑制剂、视黄醛X受体（RXR）配体及过氧化物酶增殖体活化受体γ（PPARγ）配体预处理巨噬细胞后,加入Vis,检测上述抑制剂及配体对Vis刺激效果的作用。以Vis刺激巨噬细胞，检测Vis对MAPK通路激活及对PPARγ蛋白表达的作用。结果: Vis刺激组，EMMPRIN基因及其蛋白的水平均明显增高，与对照组相比具有统计学差异（P<0.05，P<0.01）。p38 MAPK、ERK1/2 MAPK通路抑制剂及RXR配体可抑制Vis对EMMPRIN表达的促进作用。Vis可促进38 MAPK及ERK1/2 MAPK的磷酸化。结论: Vis可增加巨噬细胞炎症因子的表达，该过程同p38 MAPK及ERK1/2 MAPK通路的磷酸化相关。RXR可能参与了该过程。
Abstract:
AIM: To investigate the effect and mechanism of visfatin on extracellular matrix metalloproteinase inducer (EMMPRIN) expression in macrophages. METHODS: Thp-1 derived macrophages were stimulated with different concentrations of visfatin. EMMPRIN mRNA and protein expression were assayed by RT-PCR and Western blot. For inhibition study, cells were pretreated with MAPK inhibitors, retinoid x receptor(RXR) ligand and nuclear transcription factor peroxisome proliferator-activated receptorγ (PPARγ) ligand prior to incubation with visfatin for 24 h. Cells were also stimulated with different concentrations of visfatin to investigate the effect of visfatin on MAPK activation and PPARγ expression. RESULTS: Visfatin significantly enhanced EMMPRIN mRNA and protein expression in macrophages. p38 and ERK1/2 MAPK inhibitors as well as RXR ligand blocked this activity. Visfatin activated p38 and ERK1/2 MAPK. CONCLUSION: Visfatin enhances macrophage expression of inflammatory factors, which require p38 and ERK1/2 MAPK. RXR may mediate this activity.

参考文献/References

［1］ Chen MP, Chung FM, Chang DM, et al. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus［J］. J Clin Endocrinol Metab, 2006, 91(1):295-299.

［2］ Adya R, Tan BK, Randeva HS, et al. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis［J］. Cardiovasc Res, 2008,78(2):356-365.

［3］Huang ZQ, Wang CQ, Wei L, et al. Resveratrol inhibits EMMPRIN expression via P38 and ERK1/2pathways in PMA-induced THP-1 cells［J］. Biochem Biophys Res Commun, 2008, 374(3):517-521.

［4］Hansson GK. Inflammation, athemsclemsis, and coronary artery disease［J］. N Engl J Med, 2005, 352(16):1685-1695.

［5］Abilleira S, Bevan S, Markus HS. The role of genetic variants of matrix metalloproteinases in comnary and carotid atherosclerosis［J］. J Med Genet, 2006, 43(12):897-901．

［6］ Schmidt R, Bultmann A, Ungerer M, et al. Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction［J］. Circulation, 2006, 113(6):834-841.

［7］何清，王长谦，葛恒，等. 特异性抑制单核细胞中EMMPRIN基因表达的siRNA筛选和鉴定［J］. 上海交通大学学报（医学版）, 2007, 27(6):681-684.

［8］ Schmidt R, Bultmann A, Fischel S, et al. Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes［J］. Circ Res, 2008, 102(3):302-309.

［9］ Dahl TB, Yndestad A, Skjelland M, et al. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaquedestabilization［J］. Circulation, 2007, 115(8):972-980.

［10］Adya R, Tan BK, Chen J, et al. Pre-B cell colony enhancing factor (PBEF)/visfatin induces secretion of MCP-1 in humanendothelial cells: Role in visfatin-induced angiogenesis［J］. Atherosclerosis, 2009, 205(1):113-119.

［11］Dong C, Davis RJ, Flavell RA. MAP kinases in the immune response［J］. Annu Rev Immunol, 2002, 20:55-72.

［12］Lim M, Martinez T, Jablons D, et al. Tumor-derived EMMPRIN (extracellular matrix metalloproteinase inducer) stimulates collagenase transcription through MAPK p38［J］. FEBS Lett, 1998, 441(1):88-92.

［13］Staels B. PPAR gamma and atherosclerosis［J］. Curr Med Res Opin, 2005, 21(Suppl 1):S13-S20..

备注/Memo

备注/Memo:
收稿日期：2009-02-25.基金项目：国家自然科学基金项目资助 (30670880)；上海市科委基础研究资助项目(08XD1402600) 通讯作者：王彬尧,教授,主要从事动脉粥样硬化性心脏病的防治Email：binyaowang@hotmail.com 作者简介：范虞琪，住院医师，博士生Email：moricizine@gmail.com
更新日期/Last Update: 2010-04-09